Tuesday, 30 June 2009

Global Autoimmune Disease Therapeutics Market to Reach $50 Billion by 2015

So, no chance at all of the pharmaceutical industry promoting Low Dose Naltrexone (LDN) it would seem.

http://www.prweb.com/releases/2009/06/prweb2528754.htm

No comments:

Post a Comment